Wednesday, March 25, 2020

Strides Pharma gets EIR from USFDA on continued GMP status for Bangalore unit

The pharma company has received the Establishment Inspection Report (EIR), thereby confirming the successful closure of the inspections.

from India Infoline News Service https://ift.tt/2WINk5C
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)